Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

View:
Post by curiousbuild on Mar 23, 2016 7:03pm

Kevin oleary

suggested the short at 52wk low and buy the bonds last week. LMAO. He should track his own etfs performances. CB
Comment by biggerr on Mar 23, 2016 8:29pm
Valeant Pharmaceuticals (VRX-NYSE; VRX-TSX) Rating: Market Perform Target Price: $66.00 Total Return: 145% Price (18-Mar): $26.98 March 21, 2016 Alex Arfaei BMO Nesbitt Burns Inc. 212-885-4033 / 416-359-4
Comment by BSmartStaycalm on Mar 23, 2016 8:50pm
I have ZERO respect for the blow hard leach! Got lucky and now sucks the blood out of everything around him, thinks far too much of himself!
Comment by notwrong on Mar 24, 2016 12:36am
This post has been removed in accordance with Community Policy
Comment by Winniepup21 on Mar 24, 2016 6:18am
O'Leary Funds were some of the WORST performing funds over multiple timeframes and compared to its peer groups and indexes.  He then sold his hack shop to Canoe Financial, i do not know why they would buy from that snake oil salesmen.  oh wait!  i know why, because Chernoff and O'Leary are probably old cottage buddies.... Never trust a snakeoil salesmen.  O'Leary ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities